Investor Presentaiton
Consolidated Profit & Loss Statement
METROPOLIS
The Pathology Specialist
Profit & Loss (Rs. Crs.)
Revenue from Operations
Cost of Material Consumed
Laboratory testing charges
FY22
FY21
FY20
FY19
FY18
1,228.3
997.8
855.5
760.1
643.6
276.1
252.2
204.1
173.5
145.9
6.9
5.4
6.9
5.6
5.7
Gross Profit
945.3
740.1
644.5
581.0
492.0
Gross Profit (%)
77.0%
74.18%
75.33%
76.44%
76.44%
Employee Expenses
238.9
206.4
190.2
172.7
145.8
Other Expenses
357.6
245.7
222.4
202.8
173.7
EBIDTA
348.8
288.0
231.9
205.4
172.5
EBIDTA (%)
28.4%
28.9%
27.1%
27.0%
26.8%
Other Income
13.4
10.0
8.3
8.8
11.3
Depreciation
63.2
45.9
39.3
20.1
19.2
EBIT
299.1
252.1
201.0
188.4
164.6
EBIT (%)
24.3%
25.3%
23.5%
24.8%
25.6%
Finance Cost
21.6
7.8
7.2
0.5
1.2
Exceptional Items
15.9*
0.0
24.5
6.3
Share of Profit/Loss from JV
0.0
0.0
-0.5
-1.4
Profit Before Tax
293.4
244.3
168.7
186.5
163.4
Tax
78.7
61.0
41.2
62.9
51.8
Profit After Tax
214.7
183.3
127.6
123.6
111.6
Profit After Tax (%)
17.5%
18.4%
14.9%
16.4%
17.3%
*Exceptional Item is on account of settlement with Global Hospital of past dues
61View entire presentation